STRENGHTENS MEDICAL R&D AND IR FUNCTIONS
28.10.2019
CORRECTION: ENTERS INTO A CONSULTANCY AGREEMENT WITH JAMES BERGER – CONTEMPLATED US LISTING
18.10.2019
ENTERS INTO A CONSULTANCY AGREEMENT WITH JAMES BERGER – CONTEMPLATED US LISTING
CORRECTION: Second Quarter 2019 Financial Report
02.10.2019
SHARE CAPITAL INCREASE REGISTERED
01.10.2019
Important protein hydrolysis patent granted by the European Patent Office
30.09.2019
ESTABLISHES MANAGEMENT INCENTIVE PROGRAM – LARGE SHAREHOLDER DISCLOSURE
23.09.2019
LAST DAY OF SUBSCRIPTION PERIOD
16.09.2019
FURTHER INFORMATION ABOUT THE SUBSEQUENT OFFERING – SUBSCRIPTION PERIOD COMMENCING TODAY
02.09.2019
Second Quarter 2019 Financial Report
30.08.2019